With our innovative technologies and team of experts, we are supporting the scientific community to Achieve their goals, Advance their knowledge about protein interactions and make new Discoveries.
We ought to be the best Y2H based and nanobody partner to make breaktroughs possible.
Our history
2019
Molecular Glues (ULTImate Y2HChem)
We launch a new service for identifying PPI induced by small molecules adapted from our Y2H-based technology.2019
Genopole Biopark
We move our labs from Paris to the Genopole biotech hub to benefit from the innovative and collaborative scientific environment.2017
Hybrigenics Services SAS
We become an independently owned and operated R&D service provider with an expanding global reach.2016
HYBRIBODY
Our VHH selection and validation service is launched. We developed the technology with Institut Curie, supported by the french ANR.2013
ULTImate YChemH
We adapt our Y2H platform for target deconvolution to identify interactors of bioactive small molecules, supported by a Eurostar grant.2010
Hybrigenics Services SAS
Hybrigenics Services SAS is created as a subsidiary of Hybrigenics SA and dedicated to all fee-for-service activities.2003
Protein Interaction Platform
Our Y2H platform, primarly dedicated to internal and sub-contracting R&D, is now offered on a fee-for-service basis.2002
Cell-to Cell Mating Patent
Our unique cell-to cell-mating protocol allows to screen our highly complex cDNA libraries in an exhaustive manner.1998
Ultimate Y2H Technology
Our Proprietary Yeast Two-Hybrid technology is licensed from Institut Pasteur and further developed and optimized for commercial use.1998
Hybrigenics SA
First spin-off from Pasteur Institute is founded by R. Benarous, J. Camonis, P. Legrain, J.-C. Rain, L. Selig and D. StrosbergMeet Hybrigenics Services
Jean-Christophe Rain, PhD
CEO and CSO
In 1998, Jean-Christophe co-founded Hybrigenics and set up the company’s high-throughput protein interaction platform inherited from his PhD work at the Pasteur Institute. From 2000 to 2006, he managed internal and collaborative target ID and drug discovery programs in microbiology, virology and oncology. Jean-Christophe was Director of Technology Development and co-lead Deputy General Manager since 2010 and was promoted to CEO/CSO December of 2019 where he has enthusiastically embraced his new responsibilities.
circleJoin usBrent Passer, PhD
Director, Business Development and Sales
Petra Tafelmeyer, PhD
Director, Scientific Project Management
Marie-Edith Gourdel, PhD
Director, Chemistry and Business Development
Susanne Reichinnek, PhD
Business Development Manager and Digital Marketing Strategist
Michael Mulot, PhD
Associate, Business Development and Sales
Vincent Collura, PhD
Director, Bioinformatics & IT
Imenne Boubakour
Business Developmnet and Sales Manager
Magdalena Kopeć, PhD
Scientific Project Manager